ReviewCancers2022

PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What's Now, What's New, and What's Coming?

Andrea Marchetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.